Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
NCT06040021 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15244
Last updated 2023-09-15
Summary
The clinical and pathological features of early-onset colorectal cancer (EOCRC) differ from those of late-onset colorectal cancer (LOCRC). Our research aims to thoroughly elucidate the distinctions between them by analyzing clinical prognosis, metastatic patterns, gene expression, and genomic mutation profiles. Our deliberation will uncover latent strategies for personalized therapeutic of both EOCRC and LOCRC.
Conditions
- Early-onset Colorectal Cancer
- Late-onset Colorectal Cancer
Interventions
- OTHER
-
standardized treatment
Patients enrolled in these 2 cohorts all received standardized treatment of colorectal cancer.
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-01
- Primary Completion
- 2018-12-31
- Completion
- 2023-06-30
More Related Trials
-
MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)
NCT06879873 ·Status: NOT_YET_RECRUITING
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
NCT06614660 ·Status: ACTIVE_NOT_RECRUITING
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
NCT06643429 ·Status: ACTIVE_NOT_RECRUITING
-
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
NCT05501353 ·Status: RECRUITING
-
Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer
NCT06904677 ·Status: RECRUITING
-
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
NCT05023720 ·Status: UNKNOWN
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978 ·Status: UNKNOWN
-
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173 ·Status: RECRUITING
-
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
NCT05353582 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
NCT03794193 ·Status: UNKNOWN
-
MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)
NCT06879886 ·Status: NOT_YET_RECRUITING
-
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
NCT07309289 ·Status: RECRUITING ·Phase: PHASE3
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis
NCT05183425 ·Status: UNKNOWN
-
A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
NCT03679039 ·Status: UNKNOWN
-
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as Adjuvant Therapy for Initially Unresectable Colorectal Cancer Liver Metastases
NCT06027775 ·Status: COMPLETED
-
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
NCT06749015 ·Status: RECRUITING
-
Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.
NCT06778382 ·Status: RECRUITING ·Phase: PHASE2
-
Second Primary Cancer and Early-onset Colorectal Cancer
NCT06423924 ·Status: NOT_YET_RECRUITING
-
Maintenance Treatment With Capecitabine in Colorectal Cancer Patients
NCT02027363 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
NCT06255379 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2